Correlation Between AlzeCure Pharma and Dedicare

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both AlzeCure Pharma and Dedicare at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AlzeCure Pharma and Dedicare into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AlzeCure Pharma and Dedicare AB, you can compare the effects of market volatilities on AlzeCure Pharma and Dedicare and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AlzeCure Pharma with a short position of Dedicare. Check out your portfolio center. Please also check ongoing floating volatility patterns of AlzeCure Pharma and Dedicare.

Diversification Opportunities for AlzeCure Pharma and Dedicare

0.75
  Correlation Coefficient

Poor diversification

The 3 months correlation between AlzeCure and Dedicare is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding AlzeCure Pharma and Dedicare AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dedicare AB and AlzeCure Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AlzeCure Pharma are associated (or correlated) with Dedicare. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dedicare AB has no effect on the direction of AlzeCure Pharma i.e., AlzeCure Pharma and Dedicare go up and down completely randomly.

Pair Corralation between AlzeCure Pharma and Dedicare

Assuming the 90 days trading horizon AlzeCure Pharma is expected to under-perform the Dedicare. In addition to that, AlzeCure Pharma is 2.86 times more volatile than Dedicare AB. It trades about -0.24 of its total potential returns per unit of risk. Dedicare AB is currently generating about -0.08 per unit of volatility. If you would invest  5,860  in Dedicare AB on September 1, 2024 and sell it today you would lose (250.00) from holding Dedicare AB or give up 4.27% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy95.65%
ValuesDaily Returns

AlzeCure Pharma  vs.  Dedicare AB

 Performance 
       Timeline  
AlzeCure Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days AlzeCure Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Dedicare AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Dedicare AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

AlzeCure Pharma and Dedicare Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with AlzeCure Pharma and Dedicare

The main advantage of trading using opposite AlzeCure Pharma and Dedicare positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AlzeCure Pharma position performs unexpectedly, Dedicare can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dedicare will offset losses from the drop in Dedicare's long position.
The idea behind AlzeCure Pharma and Dedicare AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Other Complementary Tools

Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Transaction History
View history of all your transactions and understand their impact on performance
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments